nyse:bmy
|
https://www.indeed.com/cmp/celgene-corporation
|
Aug 29th, 2022 12:00AM
|
Open
|
Celgene Corporation
|
|
Pharmaceutical & Biotechnology
|
Since its inception, Celgene Corporation has devoted itself to creating medications that improve the quality of life and prolong the life expectancy for people who suffer from chronic disease. The company conducts multiple clinical trials each year and has proved extraordinarily successful at obtaining FDA and EMA approval for its various products. One of its drugs, Revlimid (generic name lenalidomide) requires such special handling that it has its own dedicated pharmacy (RevAssist) to ensure proper treatment for patients. Many of its efforts focus on multiple mylenoma, a rare form of bone marrow cancer that can cause extreme chronic pain. Celgene Corporation also creates drugs as alternatives for patients whose prior therapies proved unsuccessful.
Employees at Celgene Corporation have access to a wide range of benefits, including insurance, retirement plans, and paid vacation. The company is devoted to promoting work-life balance among its work force, which means that employees are encouraged to maintain active personal lives outside the office so they can devote more energy and effort into their work when they come into the office or lab.
Employees report that they are satisfied with the benefits that Celgene Corporation offers. They also praise the stock options programs, knowledgeable coworkers, generous bonuses, and "small company culture." Employees report that superiors encourage collaboration and reward hard work.
|
RRv1_5B_10B
|
Summit, New Jersey
|
Mark J. Alles
|
|
|
4.00
|
81.0
|
78.0
|
85.0
|
81.0
|
77.0
|
78.0
|
71.0
|
81.0
|
70.0
|
75.0
|
78.0
|
79.0
|
81.0
|
70.0
|
314.00
|
314.00
|
3.70
|
4.10
|
3.40
|
3.50
|
3.90
|
59.00
|
About a week
|
59.00
|
MEDIUM
|
59.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 01:04PM
|
Aug 29th, 2022 01:04PM
|
Bristol-Myers Squibb
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:bmy
|
https://www.indeed.com/cmp/bristol--myers-squibb
|
Aug 29th, 2022 12:00AM
|
Open
|
Bristol Myers Squibb
|
|
Pharmaceutical & Biotechnology
|
Bristol Myers Squibb is a global biopharmaceutical company committed to creating innovative medicines for millions of patients around the world fighting serious diseases in therapeutic areas such as oncology, hematology, immunology, cardiovascular and neuroscience. At the same time, we also nurture our own team with inspiring work and challenging career options.
Bristol Myers Squibb is led by our unique BioPharma strategy that combines the innovation and agility of a biotech with the reach and resources of a major pharma company. Through our R&D organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.
As global citizens, through the Bristol Myers Squibb Foundation, we promote health equity and strive to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.
|
RRv1_OVER_10B
|
345 Park Avenue New York, New York 10154-0037
|
Giovanni Caforio, M.D.
|
|
|
4.10
|
74.0
|
74.0
|
76.0
|
76.0
|
72.0
|
72.0
|
69.0
|
77.0
|
68.0
|
71.0
|
72.0
|
75.0
|
76.0
|
429.0
|
2036
|
2000
|
3.90
|
4.10
|
3.50
|
3.70
|
4.00
|
354.00
|
About two weeks
|
400.00
|
MEDIUM
|
415.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 01:04PM
|
Aug 29th, 2022 01:04PM
|
Bristol-Myers Squibb
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:bmy
|
https://www.indeed.com/cmp/myokardia,-inc.
|
Aug 29th, 2022 12:00AM
|
Open
|
MyoKardia, Inc.
|
|
|
|
RRv1_25M_100M
|
South San Francisco
|
|
|
|
5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aug 29th, 2022 01:04PM
|
Aug 29th, 2022 01:04PM
|
Bristol-Myers Squibb
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:bmy
|
https://www.indeed.com/cmp/bristol--myers-squibb
|
Aug 28th, 2022 12:00AM
|
Open
|
Bristol Myers Squibb
|
|
Pharmaceutical & Biotechnology
|
Bristol Myers Squibb is a global biopharmaceutical company committed to creating innovative medicines for millions of patients around the world fighting serious diseases in therapeutic areas such as oncology, hematology, immunology, cardiovascular and neuroscience. At the same time, we also nurture our own team with inspiring work and challenging career options.
Bristol Myers Squibb is led by our unique BioPharma strategy that combines the innovation and agility of a biotech with the reach and resources of a major pharma company. Through our R&D organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.
As global citizens, through the Bristol Myers Squibb Foundation, we promote health equity and strive to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.
|
RRv1_OVER_10B
|
345 Park Avenue New York, New York 10154-0037
|
Giovanni Caforio, M.D.
|
|
|
4.10
|
74.0
|
74.0
|
76.0
|
76.0
|
72.0
|
72.0
|
69.0
|
77.0
|
68.0
|
71.0
|
72.0
|
75.0
|
76.0
|
429.0
|
2036
|
2000
|
3.90
|
4.10
|
3.50
|
3.70
|
4.00
|
354.00
|
About two weeks
|
400.00
|
MEDIUM
|
415.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 06:05AM
|
Aug 28th, 2022 06:05AM
|
Bristol-Myers Squibb
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:bmy
|
https://www.indeed.com/cmp/celgene-corporation
|
Aug 28th, 2022 12:00AM
|
Open
|
Celgene Corporation
|
|
Pharmaceutical & Biotechnology
|
Since its inception, Celgene Corporation has devoted itself to creating medications that improve the quality of life and prolong the life expectancy for people who suffer from chronic disease. The company conducts multiple clinical trials each year and has proved extraordinarily successful at obtaining FDA and EMA approval for its various products. One of its drugs, Revlimid (generic name lenalidomide) requires such special handling that it has its own dedicated pharmacy (RevAssist) to ensure proper treatment for patients. Many of its efforts focus on multiple mylenoma, a rare form of bone marrow cancer that can cause extreme chronic pain. Celgene Corporation also creates drugs as alternatives for patients whose prior therapies proved unsuccessful.
Employees at Celgene Corporation have access to a wide range of benefits, including insurance, retirement plans, and paid vacation. The company is devoted to promoting work-life balance among its work force, which means that employees are encouraged to maintain active personal lives outside the office so they can devote more energy and effort into their work when they come into the office or lab.
Employees report that they are satisfied with the benefits that Celgene Corporation offers. They also praise the stock options programs, knowledgeable coworkers, generous bonuses, and "small company culture." Employees report that superiors encourage collaboration and reward hard work.
|
RRv1_5B_10B
|
Summit, New Jersey
|
Mark J. Alles
|
|
|
4.00
|
81.0
|
78.0
|
85.0
|
81.0
|
77.0
|
78.0
|
71.0
|
81.0
|
70.0
|
75.0
|
78.0
|
79.0
|
81.0
|
70.0
|
314.00
|
314.00
|
3.70
|
4.10
|
3.40
|
3.50
|
3.90
|
59.00
|
About a week
|
59.00
|
MEDIUM
|
59.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 06:05AM
|
Aug 28th, 2022 06:05AM
|
Bristol-Myers Squibb
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:bmy
|
https://www.indeed.com/cmp/myokardia,-inc.
|
Aug 28th, 2022 12:00AM
|
Open
|
MyoKardia, Inc.
|
|
|
|
RRv1_25M_100M
|
South San Francisco
|
|
|
|
5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aug 28th, 2022 06:05AM
|
Aug 28th, 2022 06:05AM
|
Bristol-Myers Squibb
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:bmy
|
https://www.indeed.com/cmp/myokardia,-inc.
|
Aug 27th, 2022 12:00AM
|
Open
|
MyoKardia, Inc.
|
|
|
|
RRv1_25M_100M
|
South San Francisco
|
|
|
|
5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aug 27th, 2022 05:25AM
|
Aug 27th, 2022 05:25AM
|
Bristol-Myers Squibb
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:bmy
|
https://www.indeed.com/cmp/celgene-corporation
|
Aug 27th, 2022 12:00AM
|
Open
|
Celgene Corporation
|
|
Pharmaceutical & Biotechnology
|
Since its inception, Celgene Corporation has devoted itself to creating medications that improve the quality of life and prolong the life expectancy for people who suffer from chronic disease. The company conducts multiple clinical trials each year and has proved extraordinarily successful at obtaining FDA and EMA approval for its various products. One of its drugs, Revlimid (generic name lenalidomide) requires such special handling that it has its own dedicated pharmacy (RevAssist) to ensure proper treatment for patients. Many of its efforts focus on multiple mylenoma, a rare form of bone marrow cancer that can cause extreme chronic pain. Celgene Corporation also creates drugs as alternatives for patients whose prior therapies proved unsuccessful.
Employees at Celgene Corporation have access to a wide range of benefits, including insurance, retirement plans, and paid vacation. The company is devoted to promoting work-life balance among its work force, which means that employees are encouraged to maintain active personal lives outside the office so they can devote more energy and effort into their work when they come into the office or lab.
Employees report that they are satisfied with the benefits that Celgene Corporation offers. They also praise the stock options programs, knowledgeable coworkers, generous bonuses, and "small company culture." Employees report that superiors encourage collaboration and reward hard work.
|
RRv1_5B_10B
|
Summit, New Jersey
|
Mark J. Alles
|
|
|
4.00
|
81.0
|
78.0
|
85.0
|
81.0
|
77.0
|
78.0
|
71.0
|
81.0
|
70.0
|
75.0
|
78.0
|
79.0
|
81.0
|
70.0
|
314.00
|
314.00
|
3.70
|
4.10
|
3.40
|
3.50
|
3.90
|
59.00
|
About a week
|
59.00
|
MEDIUM
|
59.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 05:25AM
|
Aug 27th, 2022 05:25AM
|
Bristol-Myers Squibb
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:bmy
|
https://www.indeed.com/cmp/bristol--myers-squibb
|
Aug 27th, 2022 12:00AM
|
Open
|
Bristol Myers Squibb
|
|
Pharmaceutical & Biotechnology
|
Bristol Myers Squibb is a global biopharmaceutical company committed to creating innovative medicines for millions of patients around the world fighting serious diseases in therapeutic areas such as oncology, hematology, immunology, cardiovascular and neuroscience. At the same time, we also nurture our own team with inspiring work and challenging career options.
Bristol Myers Squibb is led by our unique BioPharma strategy that combines the innovation and agility of a biotech with the reach and resources of a major pharma company. Through our R&D organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.
As global citizens, through the Bristol Myers Squibb Foundation, we promote health equity and strive to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.
|
RRv1_OVER_10B
|
345 Park Avenue New York, New York 10154-0037
|
Giovanni Caforio, M.D.
|
|
|
4.10
|
74.0
|
74.0
|
76.0
|
76.0
|
72.0
|
72.0
|
69.0
|
77.0
|
68.0
|
71.0
|
72.0
|
75.0
|
76.0
|
429.0
|
2036
|
2000
|
3.90
|
4.10
|
3.50
|
3.70
|
4.00
|
354.00
|
About two weeks
|
400.00
|
MEDIUM
|
415.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 05:25AM
|
Aug 27th, 2022 05:25AM
|
Bristol-Myers Squibb
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:bmy
|
https://www.indeed.com/cmp/celgene-corporation
|
Aug 25th, 2022 12:00AM
|
Open
|
Celgene Corporation
|
|
Pharmaceutical & Biotechnology
|
Since its inception, Celgene Corporation has devoted itself to creating medications that improve the quality of life and prolong the life expectancy for people who suffer from chronic disease. The company conducts multiple clinical trials each year and has proved extraordinarily successful at obtaining FDA and EMA approval for its various products. One of its drugs, Revlimid (generic name lenalidomide) requires such special handling that it has its own dedicated pharmacy (RevAssist) to ensure proper treatment for patients. Many of its efforts focus on multiple mylenoma, a rare form of bone marrow cancer that can cause extreme chronic pain. Celgene Corporation also creates drugs as alternatives for patients whose prior therapies proved unsuccessful.
Employees at Celgene Corporation have access to a wide range of benefits, including insurance, retirement plans, and paid vacation. The company is devoted to promoting work-life balance among its work force, which means that employees are encouraged to maintain active personal lives outside the office so they can devote more energy and effort into their work when they come into the office or lab.
Employees report that they are satisfied with the benefits that Celgene Corporation offers. They also praise the stock options programs, knowledgeable coworkers, generous bonuses, and "small company culture." Employees report that superiors encourage collaboration and reward hard work.
|
RRv1_5B_10B
|
Summit, New Jersey
|
Mark J. Alles
|
|
|
4.00
|
81.0
|
78.0
|
85.0
|
81.0
|
77.0
|
78.0
|
71.0
|
81.0
|
70.0
|
75.0
|
78.0
|
79.0
|
81.0
|
70.0
|
314.00
|
314.00
|
3.70
|
4.10
|
3.40
|
3.50
|
3.90
|
59.00
|
About a week
|
59.00
|
MEDIUM
|
59.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 10:03AM
|
Aug 25th, 2022 10:03AM
|
Bristol-Myers Squibb
|
Health Care
|
Pharmaceuticals & Biotechnology
|